Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Flaherty

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690U N M Rao, J Ibrahim, L E Flaherty, et al.
Cancer|March 27, 2001
Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trialsJ M Unger, L E Flaherty, P Y Liu, et al.
American Journal of Clinical Oncology|December 18, 1998
Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trialsL E Flaherty, J M Unger, P Y Liu, et al.
Cancer|July 1, 1994
Oral etoposide in the treatment of hormone-refractory prostate cancerM H Hussain, K J Pienta, B G Redman, et al.
AJR. American Journal of Roentgenology|February 1, 1990
Scintigraphic findings in patients with shoulder pain caused by interleukin-2N W Baron, L P Davis, L E Flaherty, et al.
Cancer|August 5, 2000
Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinomaC Trivedi, B Redman, L E Flaherty, et al.
Urology|August 11, 1998
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancerD C Smith, B G Redman, L E Flaherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostateK J Pienta, B Redman, M Hussain, et al.
Investigational New Drugs|January 1, 1995
Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group studyM Slavik, P Y Liu, E H Kraut, et al.
Investigational New Drugs|January 1, 1995
A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group studyJ A Sosman, L E Flaherty, P Y Liu, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690U N M Rao, J Ibrahim, L E Flaherty, et al.
Cancer|March 27, 2001
Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trialsJ M Unger, L E Flaherty, P Y Liu, et al.
American Journal of Clinical Oncology|December 18, 1998
Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trialsL E Flaherty, J M Unger, P Y Liu, et al.
Cancer|July 1, 1994
Oral etoposide in the treatment of hormone-refractory prostate cancerM H Hussain, K J Pienta, B G Redman, et al.
AJR. American Journal of Roentgenology|February 1, 1990
Scintigraphic findings in patients with shoulder pain caused by interleukin-2N W Baron, L P Davis, L E Flaherty, et al.
Cancer|August 5, 2000
Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinomaC Trivedi, B Redman, L E Flaherty, et al.
Urology|August 11, 1998
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancerD C Smith, B G Redman, L E Flaherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostateK J Pienta, B Redman, M Hussain, et al.
Investigational New Drugs|January 1, 1995
Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group studyM Slavik, P Y Liu, E H Kraut, et al.
Investigational New Drugs|January 1, 1995
A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group studyJ A Sosman, L E Flaherty, P Y Liu, et al.
Pageof 4